Results 11 to 20 of about 67,803 (296)

The Application of Nitric Oxide for Ocular Hypertension Treatment [PDF]

Molecules, 2021
Despite of various therapeutic methods for treating ocular hypertension and glaucoma, it still remains the leading cause of irreversible blindness. Intraocular pressure (IOP) lowering is the most effective way to slow disease progression and prevent ...
Binze Han, Maomao Song, Liping Li, Xinghuai Sun, Yuan Lei   +4 more
doaj   +2 more sources

Cerebral hemodynamics in ocular hypertension [PDF]

Graefe's Archive for Clinical and Experimental Ophthalmology, 2004
To evaluate the cerebral blood flow velocity in patients with ocular hypertension.Twenty-four ocular hypertensive patients and 24 age- and sex-matched healthy volunteers were recruited in a prospective comparative study. All subjects had normal findings on full-threshold visual field tests and clinically normal optic nerves.
Akarsu, Cengiz, Bilgili, Yasemin Karadeniz, Ünal, Birsen, Taner, Pelin, Ergin, Ahmet, Kara, Simay Altan   +5 more
openaire   +4 more sources

Comparison of Central Corneal Thickness and Retinal Nerve Fiber Layer Thickness and Ganglion Cell Complex in Patients with Ocular Hypertension [PDF]

Türk Oftalmoloji Dergisi, 2013
Purpose: To evaluate the correlation of retinal nerve fiber layer thickness (RNFLT) with ganglion cell complex and central corneal thickness (CCT) measurements in patients with ocular hypertension and healthy subjects.
Gamze Mumcu Taşlı, Şerife Bayraktar, Belgin İzgi, Zafer Cebeci   +3 more
doaj   +2 more sources

OCULAR HYPERTENSION - RISK FACTORS AND THERAPY? [PDF]

Sanamed, 2015
Introduction/Aim: The goal of our study was to analyze the epidemiological`s characteristics of ocular hypertension, as well as the influence of chronic risk factors on glaucoma development (conversion in glaucoma).
Janićijević Katarina, Kocic Sanja, Todorović Dušan, Šarenac-Vulović Tatjana   +3 more
doaj   +3 more sources

Glucocorticoid-Induced Ocular Hypertension and Glaucoma [PDF]

Clinical Ophthalmology
Devon Hori Harvey,1,2 Chenna Kesavulu Sugali,1,2 Weiming Mao1– 5 1Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA; 2Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN,
Harvey DH, Sugali CK, Mao W
doaj   +1 more source

Ophthalmic ocular hypertension an atypical case [PDF]

Revista de Ciencias Médicas de Pinar del Río, 2018
Introduction: phacolytic ocular hypertension is a condition where an increase in intraocular pressure is observed; which is secondary to the obstruction of the trabecular meshwork due to the deposition of high molecular weight crystalline proteins and ...
Lialys Santos Díaz, Henry Pérez González, Gianina Moreano Amaut, Aimara Beades Martínez   +3 more
doaj   +1 more source

Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension [PDF]

, 2007
Objective To test the validity and generalizability of the Ocular Hypertension Treatment Study (OHTS) prediction model for the development of primary open-angle glaucoma (POAG) in a large independent sample of untreated ocular hypertensive individuals
N. Orzalesi, Ocular Hypertension Treatment Study Group, European Glaucoma Prevention Study Group, L.M. Rossetti   +3 more
core   +3 more sources

Surveillance for ocular hypertension : an evidence synthesis and economic evaluation [PDF]

, 2012
OBJECTIVES: To determine effective and efficient monitoring criteria for ocular hypertension [raised intraocular pressure (IOP)] through (i) identification and validation of glaucoma risk prediction models; and (ii) development of models to determine ...
Banister, K, Burr, JM, Kotecha, A, Garway-Heath, D., H Lemij, M Ryan, Tuulonen, A., Vale, L., Fraser, C., R Sanders, Crabb, D, Kotecha, A., Cook, J, Y Takwoingi, S Vernon, Takwoingi, Y., Banister, K., Fraser, C, Deeks, J, Sanders, R, A Tuulonen, Cook, J., Hernández, R, Glasziou, P, Tuulonen, A, Lemij, H., Vale, L, Burr, Jennifer Margaret, Elders, A., Burr, J.M., R Asaoka, Takwoingi, Y; id_orcid, Azuara-Blanco, A, P Glasziou, Botello-Pinzon, P, Garway-Heath, D, Ryan, Mandy, Vazquez-Montes, M, Lemij, H, Deeks, J., Takwoingi, Y, D Crabb, Azuara-Blanco, A.; id_orcid, L Vale, A Azuara-Blanco, Perera, R., Ryan, M, van der Schoot, J, Perera, R, Sanders, R., Crabb, D., Elders, A, D Garway-Heath, Ryan, M., R Hernández, K Banister, C Fraser, J Cook, J van der Schoot, Botello-Pinzon, P., A Elders, A Kotecha, Glasziou, P., Azuara-Blanco, A., King, A., J Deeks, JM Burr, A King, Burr, J M, Glasziou, Paul, King, A, Vernon, S, Asaoka, R., Vazquez-Montes, M., van der Schoot, J., Vernon, S., M Vazquez-Montes, Perera, Rafael, R Perera, Asaoka, R, Hernandez, R., P Botello-Pinzon   +81 more
core   +1 more source

Bevacizumab and Panretinal photocoagulation protect against ocular hypertension after posterior subtenon injection of triamcinolone acetonide for diabetic macular edema

Journal of the Formosan Medical Association, 2017
To analyze the prognostic factors for ocular hypertension after posterior subtenon injection of triamcinolone acetonide (PSTA) for the treatment of diabetic macular edema (DME).
Yi-Ting Hsieh, Chung-May Yang, Shu-Hui Chang   +2 more
doaj   +1 more source

Long-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study [PDF]

, 2010
Background: Prospective, observational studies that enroll large numbers of patients with few exclusion criteria may better reflect actual ongoing clinical experience than randomized clinical trials.
Guzy, Claudia, Miller Paul J, Oliver Schwenn, Schwenn, Oliver, Heckmann Barbara, Paul J Miller, Schwenn Oliver, Barbara Heckmann, Claudia Guzy, Miller, Paul J., Heckmann, Barbara, Guzy Claudia   +11 more
core   +1 more source